Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · IEX Real-Time Price · USD
6.94
+0.32 (4.83%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $127.39 million as of July 26, 2024. Its market cap has decreased by -47.18% in one year.
Market Cap
127.39M
Enterprise Value
106.64M
1-Year Change
-47.18%
Ranking
Category
Stock Price
$6.94
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $127.39M, an increase of 119.62%. That is a compound annual growth rate of 37.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 121.50M | -15.92% |
| Dec 29, 2023 | 144.50M | 31.60% |
| Dec 30, 2022 | 109.80M | 89.29% |
| Feb 4, 2022 | 58.01M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 130.57M |
| American Well | 130.27M |
| Electromed | 129.06M |
| Agenus | 128.73M |
| Inventiva | 128.53M |
| Athira Pharma | 126.48M |
| FibroGen | 124.34M |
| Immunic | 124.31M |